Therapeutic Innovation & Regulatory Science

Therapeutic Innovation & Regulatory Science

治疗创新与监管科学

  • 4区 中科院分区
  • Q3 JCR分区

期刊简介

《Therapeutic Innovation & Regulatory Science》是由Springer International Publishing出版社于1997年创办的英文国际期刊(ISSN: 2168-4790,E-ISSN: 2168-4804),该期刊长期致力于医学:信息领域的创新研究,主要研究方向为MEDICAL INFORMATICS-PHARMACOLOGY & PHARMACY。作为SCI、SCIE收录期刊(JCR分区 Q3,中科院 4区),本刊采用OA未开放获取模式(OA占比0.2807...%),以发表医学:信息领域等方向的原创性研究为核心(研究类文章占比76.82%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在151篇,确保学术质量与前沿性。成果覆盖Web of ScienceWeb of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Therapeutic Innovation & Regulatory Science该刊近年未被列入国际预警名单,年发文量约151篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCI、SCIE 期刊收录
  • 151 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
MEDICAL INFORMATICS 医学:信息 PHARMACOLOGY & PHARMACY 药学
4区 3区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
MEDICAL INFORMATICS 医学:信息 PHARMACOLOGY & PHARMACY 药学
4区 4区

期刊分区表(2023年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
MEDICAL INFORMATICS 医学:信息 PHARMACOLOGY & PHARMACY 药学
4区 4区

期刊分区表(2022年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
MEDICAL INFORMATICS 医学:信息 PHARMACOLOGY & PHARMACY 药学
4区 4区

期刊分区表(2021年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
MEDICAL INFORMATICS 医学:信息 PHARMACOLOGY & PHARMACY 药学
4区 4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:MEDICAL INFORMATICS SCIE Q4 46 / 54

15.7

学科:PHARMACOLOGY & PHARMACY SCIE Q3 240 / 356

32.7

学科:MEDICAL INFORMATICS SCIE Q4 48 / 55

13.64

学科:PHARMACOLOGY & PHARMACY SCIE Q3 252 / 356

29.35

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:MEDICAL INFORMATICS SCIE Q4 36 / 44

19.3

学科:PHARMACOLOGY & PHARMACY SCIE Q3 222 / 354

37.4

学科:MEDICAL INFORMATICS SCIE Q4 41 / 44

7.95

学科:PHARMACOLOGY & PHARMACY SCIE Q4 276 / 354

22.18

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:4.3 SJR:0.902 SNIP:1.154
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmacology, Toxicology and Pharmaceutics (miscellaneous) Q1 12 / 57

79%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Public Health, Environmental and Occupational Health Q2 231 / 725

68%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmacology (medical) Q2 123 / 278

55%

期刊发文

  • Adverse Events Associated with Clascoterone: A Real-World Pharmacovigilance Study of the Food and Drug Administration Adverse Event Reporting Syste

    Author: Tao, Li; Zhang, Mengying; Zhang, Wenyue; Feng, Peishi; Zhou, Min; Wang, Ping

    Journal: THERAPEUTIC INNOVATION & REGULATORY SCIENCE. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s43441-026-00968-2

  • Mapping the evolution of cell and gene therapy product research: trends, collaborations, and emerging frontier

    Author: Rao, Yanmei; Dong, Li; Huang, Zhe

    Journal: THERAPEUTIC INNOVATION & REGULATORY SCIENCE. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s43441-025-00913-9

  • Applications and Challenges of Artificial Intelligence and Big Data in Drug Regulatio

    Author: Liu, Zhao; Zheng, Yang; Fang, Jun; Yuan, Lin

    Journal: THERAPEUTIC INNOVATION & REGULATORY SCIENCE. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s43441-026-00946-8

  • Ethical Challenges and Considerations in Decentralized Clinical Trials (DCTs): Insights from a Scoping Revie

    Author: Han, Lijia; Ooi, Kai Hong; Balakrishnan, Krisna Veni; Phan, Chia Wei

    Journal: THERAPEUTIC INNOVATION & REGULATORY SCIENCE. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s43441-026-00949-5

  • Research on the Quality Evaluation Indicators of Real-World Data in the Review of Anti-Tumor Drugs for Chinese Regulatory Framework

    Author: Zhang, Jie-ying; Tang, Yong; Dong, Fang-zheng; Mao, Ning-ying; Li, Jun

    Journal: THERAPEUTIC INNOVATION & REGULATORY SCIENCE. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s43441-026-00943-x

  • Application of Artificial Intelligence in MedDRA Coding: A Practical Exploration from Clinical Data Management Perspectiv

    Author: Yan, Charles; Yang, Ruier; Yan, Huaihai; Wei, Xin; Zhou, Erkang; Zhao, Shouzhu; Zhuang, Yonglong

    Journal: THERAPEUTIC INNOVATION & REGULATORY SCIENCE. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s43441-026-00953-9

  • Patent Analysis Perspectives on China's Orphan Drug R&D: Status and Technology Characteristic

    Author: Jiao, Yang; Yuan, Fangzhe; Liu, Tianyu; Han, Jiajia; Sun, Jingchun; Chu, Shuzhen; Li, Shuxiang

    Journal: THERAPEUTIC INNOVATION & REGULATORY SCIENCE. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s43441-026-00927-x

  • Advancing AI Ethics Frameworks in Drug Development: Global Applicability, Practical Challenges, and Dynamic Governanc

    Author: Chen, Kai; Yu, Zekai

    Journal: THERAPEUTIC INNOVATION & REGULATORY SCIENCE. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s43441-025-00814-x